Table 1.
Baseline characteristics according to the clinical stage of hepatitis B virus or hepatitis B virus/hepatitis delta virus infection
| Total, n = 24 | Chronic HBV infection, n = 7 | Chronic hepatitis B, n = 8 | Chronic hepatitis delta, n = 9 | P value | |
| Age, yr, median (IQR) | 36.5 (30.75-48) | 40 (33.5-60.5) | 35.5 (32.75-42) | 38 (30-41) | ns |
| Male, n (%) | 14 (58) | 4 (57) | 4 (50) | 6 (67) | ns |
| Ethnic group, n (%) | |||||
| Caucasian | 17 (71) | 5 (71) | 5 (62) | 7 (78) | ns |
| Sub-Saharan | 7 (29) | 2 (29) | 3 (38) | 2 (22) | |
| ALT, IU/L, median (IQR) | 43 (31.75-118.5) | 27 (16-30.5) | 60 (44.25-118.5) | 80 (39-138) | 0.0007 |
| HBeAg-, n (%) | 19 (79) | 7 (100) | 8 (100) | 4 (44) | 0.005 |
| HBsAg, logIU/mL, median (IQR) | 3.8 (3.5-4.1) | 3.6 (2.6-3.9) | 3.6 (3.4-3.7) | 4.1 (3.8-4.5) | 0.0152 |
| HBV DNA, logIU/mL, median (IQR) | 3.5 (3.2-5.4) | 3.2 (2.8-3.4) | 5.4 (3.9-6.2) | 3.4 (3.2-4) | 0.0038 |
| HDV RNA, logIU/mL, median (IQR) | 5.5 (4.3-5.5) | - |
IQR: Interquartile range; ALT: Alanine aminotransferase; HBeAg: Hepatitis B e-antigen; HBsAg: Hepatitis B virus surface antigen; HBV: Hepatitis B virus; HDV: Hepatitis delta virus.